NOTE DUE November 26, 2019Generex Biotechnology Corp • December 3rd, 2018 • Pharmaceutical preparations • New York
Company FiledDecember 3rd, 2018 Industry JurisdictionTHIS NOTE is one of a series of duly authorized and validly issued Notes of Generex Biotechnology Corporation, a Delaware corporation, (the “Borrower”), having a place of business at 10102 USA Today Way, Miramar, Florida 33025, email: josephmoscatojr@gmail.com, due November 26, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
NOTE DUE OCTOBER 26, 2019Generex Biotechnology Corp • October 26th, 2018 • Pharmaceutical preparations • New York
Company FiledOctober 26th, 2018 Industry JurisdictionTHIS NOTE is one of a series of duly authorized and validly issued Notes of Generex Biotechnology Corporation, a Delaware corporation, (the “Borrower”), having its principal place of business at 4145 North Service Road, Suite 200, Burlington, Ontario, Canada L7L 6A3, email: mfletcher@generex.com, due October 26, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).